Breaking News, Financial News

Financial Report: WuXi PharmaTech

Revenues up 29% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech   2Q Revenues: $130.4 million (+29%) 2Q Earnings: $20.5 million (+10%) YTD Revenues: $248.4 million (+28%) YTD Earnings: $41.5 million (+12%) Comments: Laboratory Services revenues grew 25% in the quarter to $93.6 million. China-Based Lab Services revenue was up 27% to $70.3 million. U.S.-Based Lab Services revenue was up 18% to $23.3 million. Manufacturing Services revenue grew 41% to $36.8 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters